bioRxivCell Biology
Regulation of Blos1 by IRE1 prevents the accumulation of Huntingtin protein aggregates
D. Bae, R. E. Jones, K. M. Piscopo, M. Tyagi, J. D. Shepherd, J. Hollien
Abstract
Huntingtons disease is characterized by accumulation of the aggregation-prone mutant Huntingtin (mHTT) protein. Here, we show that expression of mHTT in mouse cultured cells activates IRE1, the transmembrane sensor of stress in the endoplasmic reticulum, leading to degradation of the Blos1 mRNA and repositioning of lysosomes and late endosomes toward the microtubule organizing center. Overriding Blos1 degradation results in excessive accumulation of mHTT aggregates in both cultured cells and primary neurons. Although mHTT is degraded by macroautophagy when highly expressed, we show that prior to the formation of large aggregates, mHTT is degraded via an ESCRT-dependent, macroautophagy-independent pathway consistent with endosomal microautophagy. This pathway is enhanced by Blos1 degradation and appears to protect cells from a toxic, less aggregated form of mHTT. Condensed titleBlos1 regulation protects from Huntingtin aggregation Short summaryHere the authors demonstrate that the regulation of Blos1 by the unfolded protein response prevents the excessive accumulation of Huntingtin, the protein that underlies Huntingtons disease. This pathway involves the macroautophagy-independent degradation of Huntingtin prior to its forming large aggregates.
- organism: mouse
- assay: proteomics
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties
Nathan Riguet, Anne‐Laure Mahul‐Mellier, … Hilal Ahmed Lashuel·Nature CommunicationsPeer-reviewed·Nov 12, 2021
- TBK1 regulates autophagic clearance of soluble mutant huntingtin and inhibits aggregation/toxicity in different models of Huntington's disease
Ramanath Narayana Hegde, Anass Chiki, … Hilal Ahmed Lashuel·bioRxiv·Dec 10, 2019
- Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates
Paula García-Huerta, Paulina Troncoso-Escudero, … Claudio A. Hetz·Acta NeuropathologicaPeer-reviewed·Jul 8, 2020
- Development of a novel VHH intrabody targeting the N17 region of huntingtin exon 1 protein that prevents inclusion body formation.
Florence D.M. Wavreil, Wouter Pos, … Eric A. Reits·bioRxiv·Apr 13, 2026
- Optineurin promotes aggregation of mutant huntingtin and mutant ataxin-3, and reduces cytotoxicity of aggregates
Shivranjani C Moharir, Akhouri Kishore Raghawan, G. Swarup·bioRxiv·Aug 13, 2020
- Feeding Schedule And Proteolysis Regulate Autophagic Clearance Of Mutant Huntingtin
Dagmar E. Ehrnhoefer, Dale D. O. Martin, … Michael R. Hayden·Acta Neuropathologica CommunicationsPeer-reviewed·Feb 26, 2018